47.95 USD
↘ 1.15 (2.34%)PRE MARKET (AS OF 09:23 AM EDT)
QURE is currently priced at $47.95. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 25, 2026.
Open?$49.46
High?$49.46
Low?$47.70
Prev. Close?$49.10
Volume?15.1K
Avg. Volume?2.4M
VWAP?$48.56
Rel. Volume?0.01x
Bid / Ask
Bid?$42.18 × 100
Ask?$55.98 × 100
Spread?$13.80
Midpoint?$49.08
Valuation & Ratios
Market Cap?3.1B
Shares Out?63.1M
Float?55.9M
Float %?89.4%
P/E Ratio?N/A
P/B Ratio?20.73
EPS?-$3.31
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.
Themes
Address
PAASHEUVELWEG 25A
AMSTERDAM, 1105 BP
Phone: 1-339-970-7000
AMSTERDAM, 1105 BP
Phone: 1-339-970-7000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?23
Z-Score?6
Momentum?65
Short Sent.?40
Piotroski F-Score?3/9Weak
Altman Z-Score?0.57Distress
Confidence?63%Moderate
Short InterestSqueeze Risk
Short % of Float?21.13%Squeeze Risk
Short Interest?11.8M
Days to Cover?8.2
Free Float55.9M
Avg Daily Volume1.4M
Settlement Date2026-06-15
Financial Health
Current Ratio?10.40Strong
Quick Ratio?10.40Strong
Cash Ratio?2.36Strong
Debt/Equity?0.33Low
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?20.73HIGH▾
Peers100
S&P7
P/S?171.15HIGH▾
Peers100
S&P3
P/FCF?N/A▾
EV/EBITDA?-17.7CHEAP▾
S&P97
EV/Sales?166.17HIGH▾
Peers100
S&P3
Returns & Efficiency
ROE?-139.9%WEAK▾
S&P3
ROA?-26.8%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-172559000
Enterprise Value?$3.0B
Fundamentals ratios updated end of day